Table 1

Demographic, clinical, radiological and laboratory findings

Patient 1Patient 2Patient 3Patient 4Patient 5Patient 6
Demographic characteristics
Age, years645385618373
SexMaleFemaleMaleMaleMaleMale
Medical historyNilHypertension, diabetes, mitral valve replacement, atrial fibrillation, heart failure with a permanent pacemakerHypertension, hypercholesterolaemia, atrial fibrillation, ischaemic heart disease, prostate cancer (Gleason Score 4+5)Hypertension, stroke, chronic leg ulcersHypertension, diabetes, ischaemic heart disease, smoking and alcohol consumptionGastric carcinoma (resected), benign essential tremor
Symptoms at COVID-19 disease onsetCough, shortness of breath, fever, myalgia, loss of appetiteMalaise, dry cough, shortness of breath, feverCoughFever, cough, shortness of breath, tachypnoeaFever, cough, shortness of breath, fatigueShortness of breath, tachypnoea
Initial treatmentAntibiotics, oxygen therapySupportiveSupportiveAntibioticsAntibiotics, oxygen therapyAntibiotics, oxygen therapy
Days from COVID-19 symptom onset to ischaemic stroke symptom onset152410−2 (stroke preceded COVID-19 symptoms by 2 days)158
Clinical symptoms of ischaemic strokeWord-finding difficulties, bilateral incoordination, right homonymous hemianopiaAcute confusion, incoordination, reduced consciousness
(GCS 13/15)
Dysarthria, right facial droop and right-sided weaknessDysarthria, left facial droop and left-sided weaknessDysarthria, left facial droop, left-sided weakness and left-sided sensory inattentionAphasia, right facial droop and right-sided weakness
ICU admission and disease severity
Days from COVID-19 symptom onset to ICU admission1425Did not go to
ICU
Did not go to ICUDid not go to ICUDid not go to ICU
COVID-19 disease severitySevereCriticalModerate to severeModerateSevereSevere
Laboratory findings on the day of first or only ischaemic stroke event
Haemoglobin (g/L)119↓94↓128↓126↓121↓142
White cell count (/mm3)675023 050↑5080897011 030↑7300
Differential count (/mm3)
Neutrophils581019 200↑444063908330↑5800
Lymphocytes470↓2070402↓13101630890↓
Monocytes3701660↑180↓900830470
Platelet count (/mm3)305 000254 000173 000408 000↑197 000403 000↑
Albumin (g/L)28↓28↓33↓31↓32↓32↓
Alanine aminotransferase (U/L)137 ↑2732243775 ↑
Bilirubin (µmol/L)1129↑17131110
Lactate dehydrogenase (U/L)654↑664↑461↑444↑353↑439↑
Creatinine (μmol/L)57757710710068
EGFR (ml/min/1.73 m2)>9074876364>90
High-sensitivity cardiac troponin I (pg/ml)942↑32 ↑30↑66↑8
Prothrombin time (s)12.5↑34.4↑11.310.911.712.3↑
International normalised ratio (INR)1.143.6↑*1.030.991.071.13
Activated partial-thromboplastin time (APPT) (s)3541↑ *3324↓3032
APPT ratio1.11.3↑10.81.01
Fibrinogen (g/L)9.5 ↑7.035.3↑4.63↑4.96↑
D-dimer (μg/L)>80 000 ↑7,750↑16,100↑27,190↑19,450↑1,080↑
Serum ferritin (μg/L)4927 ↑1,853↑1,027↑1,167↑655↑
High-sensitivity C reactive protein (mg/L)305.4 ↑150.1↑161.2↑12.827.7↑179.9↑
Antiphospholipid antibodies:
Anticardiolipin (aCL)
Anti-β2-glycoprotein-1 (aβ2GPI)
Medium titre IgM aCL
IgG aCL negative
Low titre IgG and IgM aβ2GP1
IgG and IgM aCL and aβ2GP1 negativeIgG and IgM aCL
and aβ2GP1
negative
IgG and IgM aCL and aβ2GP1 negativeIgG and IgM aCL and aβ2GP1 negativeIgG and IgM aCL and aβ2GP1 negative
Lupus anticoagulantPositivePositiveNegativePositivePositivePositive
Imaging features
Brain
(see online supplementary figure S1s and S2)
MRI including diffusion-weighted and susceptibility-weighted imaging showed acute left vertebral artery thrombus and acute left posterior-inferior cerebellar artery territory infarction with petechial haemorrhagic transformation. 7 days later, diffusion-weighted MRI showed bilateral acute posterior cerebral artery territory infarcts despite therapeutic anticoagulationNon-contrast CT showed acute right parietal cortical and left cerebellar infarct with mass effect and hydrocephalus, despite therapeutic anticoagulationNon-contrast CT showed hyperdensity consistent with thrombus in the left posterior cerebral artery and acute infarction in the left temporal stem and cerebral peduncleDiffusion-weighted MRI showed acute infarction in the right corpus striatum suggesting transient occlusion of the M1 segment of the right middle cerebral artery; fluid attenuated inversion recovery MRI showed an established infarct in the same region with moderate background cerebral small vessel diseaseCT and CT angiogram showed thrombotic occlusion of a proximal M2 branch of the right middle cerebral artery; a repeat CT at 24 hours showed a focus of parenchymal low density involving the right insular cortex in keeping with an evolving right middle cerebral artery territory infarctDiffusion-weighted MRI showed acute infarction in the right thalamus, left pons, right occipital lobe and right cerebellar hemisphere. Time-of-flight images showed thrombotic material in the basilar artery and bilateral mild-to-moderate P2 segment stenosis
ChestChest X-ray: Bilateral pulmonary infiltrates
CT pulmonary angiogram: Bilateral pulmonary embolism; semiocclusive right middle lobe segmental and right lower lobe subsegmental, non-occlusive lower lobe subsegmental embolus
CT chest: Bilateral ground-glass change and consolidation
CT pulmonary angiogram: No large pulmonary embolus within the main or segmental pulmonary arteries
Chest X-ray: Bilateral peripheral airspace opacities throughout both lungs, worse on the rightCT chest: Bilateral patchy subpleural airspace opacification in both lungs
CT pulmonary angiogram: Pulmonary embolus in the left upper lobe segmental artery
Chest X-ray: few ill-defined patchy airspace opacifications seen peripherally in both lung fields mid-zones and lower zones, mild amount right-sided pleural effusion.
CT pulmonary angiogram: No large pulmonary embolus within the main or segmental pulmonary arteries
Chest X-ray: Bilateral predominantly peripheral airspace opacities, most confluent at the mid-zones and the lung bases
CT pulmonary angiogram: No large pulmonary embolus within the main or segmental pulmonary arteries
Other vascular imagingLower limb Doppler ultrasound: occlusive DVT in the left posterior tibial vein and the left peroneal vein
  • *Patient taking warfarin.

  • DVT, Deep Vein Thrombosis ; EGFR, Estimated Glomerular Filtration Rate; GCS, Glasgow Coma Score ; ICU, intensive care unit.